88 related articles for article (PubMed ID: 8545123)
1. Induction of apoptosis by rho in NIH 3T3 cells requires two complementary signals. Ceramides function as a progression factor for apoptosis.
Esteve P; del Peso L; Lacal JC
Oncogene; 1995 Dec; 11(12):2657-65. PubMed ID: 8545123
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in NIH3T3 cells after serum deprivation by overexpression of rho-p21, a GTPase protein of the ras superfamily.
Jiménez B; Arends M; Esteve P; Perona R; Sánchez R; Ramón y Cajal S; Wyllie A; Lacal JC
Oncogene; 1995 Mar; 10(5):811-6. PubMed ID: 7898922
[TBL] [Abstract][Full Text] [Related]
3. Tumorigenic activity of rho genes from Aplysia californica.
Perona R; Esteve P; Jiménez B; Ballestero RP; Ramón y Cajal S; Lacal JC
Oncogene; 1993 May; 8(5):1285-92. PubMed ID: 8479750
[TBL] [Abstract][Full Text] [Related]
4. GTP-binding protein-stimulated phospholipase C and phospholipase D activities in ras-transformed NIH 3T3 fibroblasts.
Quilliam LA; Der CJ; Brown JH
Second Messengers Phosphoproteins; 1990; 13(1):59-67. PubMed ID: 2149569
[TBL] [Abstract][Full Text] [Related]
5. Activation of type D phospholipase by serum stimulation and ras-induced transformation in NIH3T3 cells.
Carnero A; Cuadrado A; del Peso L; Lacal JC
Oncogene; 1994 May; 9(5):1387-95. PubMed ID: 8152799
[TBL] [Abstract][Full Text] [Related]
6. Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl2 dependent pathway.
Esteve P; Embade N; Perona R; Jiménez B; del Peso L; León J; Arends M; Miki T; Lacal JC
Oncogene; 1998 Oct; 17(14):1855-69. PubMed ID: 9778052
[TBL] [Abstract][Full Text] [Related]
7. Detection of phosphatidylcholine-specific phospholipase C in NIH-3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies.
Podo F; Ferretti A; Knijn A; Zhang P; Ramoni C; Barletta B; Pini C; Baccarini S; Pulciani S
Anticancer Res; 1996; 16(3B):1399-412. PubMed ID: 8694508
[TBL] [Abstract][Full Text] [Related]
8. Ral and Rho-dependent activation of phospholipase D in v-Raf-transformed cells.
Frankel P; Ramos M; Flom J; Bychenok S; Joseph T; Kerkhoff E; Rapp UR; Feig LA; Foster DA
Biochem Biophys Res Commun; 1999 Feb; 255(2):502-7. PubMed ID: 10049738
[TBL] [Abstract][Full Text] [Related]
9. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
10. Cell and tissue-type specific expression of Ras-related GTPase RhoB.
Fritz G; Gnad R; Kaina B
Anticancer Res; 1999; 19(3A):1681-8. PubMed ID: 10470101
[TBL] [Abstract][Full Text] [Related]
11. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
Xin H; Geng Y; Pramanik R; Choubey D
J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
[TBL] [Abstract][Full Text] [Related]
12. Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.
Mazières J; Tillement V; Allal C; Clanet C; Bobin L; Chen Z; Sebti SM; Favre G; Pradines A
Exp Cell Res; 2005 Apr; 304(2):354-64. PubMed ID: 15748883
[TBL] [Abstract][Full Text] [Related]
13. Dominant-negative Rac1 suppresses Ras-induced apoptosis possibly through activation of NFkappaB in Ha-ras oncogene-transformed NIH/3T3 cells.
Chou CK; Liang KH; Tzeng CC; Huang GC; Chuang JI; Chang TY; Liu HS
Life Sci; 2006 Mar; 78(16):1823-9. PubMed ID: 16274703
[TBL] [Abstract][Full Text] [Related]
14. Decreased retinoylation in NIH 3T3 cells transformed with activated Ha-ras.
Takahashi N; De Luca LM; Breitman TR
Biochem Biophys Res Commun; 1997 Oct; 239(1):80-4. PubMed ID: 9345273
[TBL] [Abstract][Full Text] [Related]
15. Mitogenic phospholipase D activity is restricted to caveolin-enriched membrane microdomains.
Xu L; Shen Y; Joseph T; Bryant A; Luo JQ; Frankel P; Rotunda T; Foster DA
Biochem Biophys Res Commun; 2000 Jun; 273(1):77-83. PubMed ID: 10873567
[TBL] [Abstract][Full Text] [Related]
16. A low molecular weight factor from dividing cells activates phospholipase D in caveolin-enriched membrane microdomains.
Bychenok S; Foster DA
Arch Biochem Biophys; 2000 May; 377(1):139-45. PubMed ID: 10775453
[TBL] [Abstract][Full Text] [Related]
17. Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton.
Koch G; Benz C; Schmidt G; Olenik C; Aktories K
J Pharmacol Exp Ther; 1997 Nov; 283(2):901-9. PubMed ID: 9353412
[TBL] [Abstract][Full Text] [Related]
18. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
[TBL] [Abstract][Full Text] [Related]
19. Rho small G protein and cytoskeletal control.
Takai Y; Kaibuchi K; Sasaki T; Tanaka K; Shirataki H; Nakanishi H
Princess Takamatsu Symp; 1994; 24():338-50. PubMed ID: 8983086
[TBL] [Abstract][Full Text] [Related]
20. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
Zohar M; Teramoto H; Katz BZ; Yamada KM; Gutkind JS
Oncogene; 1998 Aug; 17(8):991-8. PubMed ID: 9747878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
